View Partner Button
Picture of researcher

Cancer Clinical Trials

Site: Gastrointestinal

The most recent listing of current clinical trials for gastrointestinal cancers — including colon, rectal, anal and gastroesophageal —  appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
 

Site: Gastrointestinal
(Includes Colon, Rectal, Anal
and Gastroesophageal)

Protocol ID    Title

Memorial Sloan Kettering
(also in thoracic)
   A Random Assignment Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) versus Parent DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma

Keywords: Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarinoma

NSABP FC-6
Also in liver
   A Phase II Study to Determine the Surgical Conversion Rate in Patients Receiving Neoadjuvant mFOLFOX7 Plus Cetuximab for Unresectable Wild-Type K-RAS Colorectal Cancer with Metastases Confined to the Liver

Keywords: Colorectal Cancer with Metastases Confined to the Liver

TR321
   A Double-Blind, Randomized Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome

Keywords: Carcinoid Syndrome

DEBIRI (also in Liver)
   Precision Irinotecan Therapy of Liver Metastasis from Colon Cancer with Concomitant Systematic Oxaliplatin, Fluorouracil and Leucovorin Chemotherapy and Avastin Therapy

Keywords: Liver Metastasis from Colon Cancer

I4T-MC-JVBB
   A Randomized, Double-Blind, Multicenter Phase III Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) plus Ramucirumab or Placebo in Patients with Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy with Bevacizumab, Oxaliplatin, and a Fluoropyrimidine

Keywords: Patients with Metastatic Colorectal Carcinoma

RTOG-1010
(also in thoracic)
   A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal Adenocarcinoma

Keywords: Esophageal Adenocarcinoma

Industry
(also in liver)
   Randomized Comparative Study of FOLFOX 6m Plus Sir-Spheres Microspheres v. FOLFOX 6m Alone as First Line Treatment in Patients with Nonresectable Liver Metastases from Primary Colorectal Carcinoma

Keywords: Nonresectable Liver Metastases from Primary Colorectal Carcinoma

 

 

Last Review Date: Jan. 31, 2012

Online Editor(s): Richard Petre

e-Newsletters

Monthly articles about the health topics of your choice!

Sign Up Today Sign Up Today

Log In to My Froedtert Log In to My Froedtert

Related Information
Quick Links
© 2012 Froedtert & The Medical College of Wisconsin
9200 West Wisconsin Avenue
Milwaukee, WI 53226